Bartushak Jaime 4
4 · Citius Pharmaceuticals, Inc. · Filed Sep 6, 2018
Insider Transaction Report
Form 4
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase Common Stock)
2018-09-04+70,000→ 70,000 totalExercise: $1.62Exp: 2028-09-04→ Common Stock (70,000 underlying)
Holdings
- 25,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-15→ Common Stock (25,000 underlying) - 48,267
Stock Option (Right to Purchase Common Stock)
Exercise: $10.50Exp: 2026-06-06→ Common Stock (48,267 underlying) - 60,353
Common Stock
Footnotes (3)
- [F1]One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.
- [F2]On September 15, 2017 the Reporting Person was granted a ten-year option to purchase 25,000 shares of common stock at an exercise price of $3.45 per share. The options vest as follows: 8,333 shares vest on September 13, 2018, and then 694 shares per month for the next 24 months.
- [F3]On July 6, 2016 the Reporting Person was granted a ten-year option to purchase 48,267 shares of common stock at an exercise price of $10.50 per share. The options vest as follows: 16,089 shares vest on July 7, 2017, and then 1,341 shares per month for the next 24 months